Navigation Links
Raptor Pharmaceutical Corp. Announces $7.5 Million Securities Offering
Date:12/18/2009

NOVATO, Calif., Dec. 18 /PRNewswire-FirstCall/ -- Raptor Pharmaceutical Corp. ("Raptor" or the "Company") (Nasdaq: RPTP), today announced that it has entered into definitive agreements with institutional investors to purchase 3,747,558 units for gross proceeds of approximately $7.5 million, before placement agent fees and offering expenses.

(Logo: http://www.newscom.com/cgi-bin/prnh/20071022/NYM074LOGO)

The offering is made pursuant to the Form S-3 shelf registration statement that was filed by Raptor with the Securities and Exchange Commission (the "SEC"). The offering is expected to close on or about December 22, 2009, subject to the satisfaction of customary closing conditions. Raptor intends to use the net proceeds from the offering for general corporate purposes, including activities related to further clinical development of DR Cysteamine and for other working capital and operational purposes.

The securities sold in this offering consist of one share of common stock and one warrant to purchase 0.5 of a share of common stock for a period of five years and one warrant to purchase 0.5 of a share of common stock for a period of 18 months. Both warrants have an exercise price of $2.45 per share of common stock and are exercisable starting with the date that is 180 days from the closing of the offering. The shares of common stock and warrants are immediately separable and will be issued separately.

Ladenburg Thalmann & Co. Inc., a subsidiary of Ladenburg Thalmann Financial Services Inc. (Amex: '/>"/>

SOURCE Raptor Pharmaceutical Corp.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Raptor Pharmaceutical Corp. Announces Positive Data on NGX426 in the Potential Treatment of Neuropathic Pain
2. Raptor Pharmaceutical Completes DR Cysteamine Phase 2b Clinical Trial in Cystinosis
3. Raptor Pharmaceutical Corporation Announces Presentation of Data for NGX426, a Novel, Non-Opioid Oral Analgesic, at Neuropathic Pain Conference
4. Merriman Curhan Ford Acted as Financial Advisor to TorreyPines Therapeutics, Inc. in the Completed Merger With Raptor Pharmaceuticals Corp.
5. Raptor Pharmaceutical Expands Board of Directors
6. Raptor Pharmaceuticals Corp. and TorreyPines Complete Merger
7. Raptor Pharmaceuticals Receives Notices of Allowance for Two NeuroTrans(TM) Patent Applications
8. Raptor Pharmaceuticals Appoints Dr. Patrice P. Rioux as Chief Medical Officer
9. Raptor Pharmaceuticals Announces Completion of Patient Enrollment in Phase 2a Clinical Trial in Non-Alcoholic Steatohepatitis (NASH)
10. Raptor Pharmaceuticals Corp. Announces Positive Phase IIa Clinical Study Results for Convivia(TM) Program
11. Raptor Pharmaceuticals to Collaborate with Centre Hospitalier Universitaire dAngers for Phase II Clinical Trial in Huntingtons Disease
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2014)... , July 23, 2014 Research ... "Disposable Medical Gloves (Exam and Surgical) Markets Worldwide ... http://photos.prnewswire.com/prnh/20130307/600769 The purpose of ... market for Disposable Medical (Exam and Surgical) Gloves. The ... market for these products. Topics covered include ...
(Date:7/23/2014)... 23, 2014  The management team at Columbia ... hold a conference call on July 31, 2014, ... ended June 30, 2014.  The call details are ... 8:30 am EDTDial-in numbers: , Toll free: (877) ... (live & archive): , www.columbialabs.com , under ...
(Date:7/23/2014)...  Silk Road Medical, Inc., a developer of ... and extra-cranial cerebrovascular disease, announced today the appointment ... position of Chief Technology Officer.  In this new ... Development efforts across its family of transcarotid access ... joining Silk Road Medical, Michael was the Vice ...
Breaking Medicine Technology:Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 2Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 3Disposable Medical Gloves (Exam and Surgical) Markets Worldwide 2014 4Columbia Laboratories to Discuss Second Quarter 2014 Financial Results on July 31st Conference Call 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 2Silk Road Medical Appoints Ground Breaking Innovator as Chief Technology Officer 3
... announces that a new market research report is available ... of Xylose in China http://www.reportlinker.com/p0260046/Production-and-Market-of-Xylose-in-China.html ... global financial crisis in Q4 2008, Chinese xylose production ... or even stopped production due to declining profit and ...
... improve vision-related quality of life in children compared with ... according to data drawn from a three-year multi-site study ... the self-perception of nearsighted children ages eight to 11 ... may be more considerable after 10 years of age. ...
Cached Medicine Technology:Reportlinker Adds Production and Market of Xylose in China 2Reportlinker Adds Production and Market of Xylose in China 3Children Report Better Vision-Related Quality of Life with Contact Lenses vs. Glasses 2
(Date:7/23/2014)... (PRWEB) July 23, 2014 The puffiness ... diminished using non-surgical techniques, according to a new guide ... eyes serum sold in the U.S. is now available ... . , The complimentary guide that is now published ... struggle with under eye puffiness. While surgical techniques are ...
(Date:7/23/2014)... near Sellafield or Dounreay since the 1990s are not ... research published in the British Journal of Cancer ... Research Group at the University of Oxford and from ... among those who were under 25 and living near ... in cancer incidence from 1991-2006 between those living near ...
(Date:7/23/2014)... 23, 2014 Home Care ... of in-home care for seniors, announces the next ... featuring experts in a wide range of health ... licensed clinical social worker and award-winning author Nancy ... of caregiver stress and ways to prevent burnout ...
(Date:7/23/2014)... Lake Worth, FL (PRWEB) July 23, 2014 ... will take place Aug. 10-16, Millennium Treatment Group is ... Substance abuse has existed in society ever since man ... make wine. Substance abuse treatment has existed since shortly ... of recognizing a problem and then developing a way ...
(Date:7/23/2014)... Alan Mozes HealthDay Reporter ... servicemen are more likely to have been exposed to some ... new survey suggests. The finding seems to apply solely ... that the finding could be a cause for concern, given ... and/or sexual abuse among the civilian population has been linked ...
Breaking Medicine News(10 mins):Health News:Puffy Eyes Serum Explored in Complimentary Guide Released at Consumer News Website 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 2Health News:Oklahoma Home Care Assistance Hosting Caregiver Mindfulness Webinar Tomorrow 3Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 2Health News:Millennium Treatment Group Offers Tips on Choosing a Reputable Treatment Center 3Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 2Health News:Many U.S. Male Soldiers Had Troubled Childhoods, Study Finds 3
... Allscripts-Misys Healthcare,Solutions, Inc. (formerly named Allscripts Healthcare ... Delaware ("Allscripts") and,headquartered in Chicago, Illinois announced today ... 3.50% Convertible Senior Debentures due 2024 (the,"Debentures") at ... equal to 100% of the principal amount of ...
... 7 Sagent Pharmaceuticals, Inc.,a privately-held specialty pharmaceutical company ... and Chief Executive,Officer Jeffrey M. Yordon will be presenting ... as follows., November: -- Jeffrey M. ... Annual Healthcare Conference on Wednesday, ...
... BioActiveX3 Complex(TM) features toxin-free ingredients, green chemistry technology in self-adjusting ... ... SALT LAKE CITY, Nov. 7 Global nutrition leader XanGo,LLC, today ... international convention in Salt Lake City. This personal care,brand features exclusive ...
... Society of ... Nephrology, HAYWARD, Calif., ... indicating that,its therapeutic product candidate AC-200 improved bone architecture in a,rat model ... was evaluated in a well accepted rodent model of,chronic kidney disease (CKD) ...
... Inc.,(Nasdaq: ENMD ) a clinical-stage pharmaceutical company ... diseases,announced today that James S. Burns, President and ... the Rodman and Renshaw 10th Annual,Healthcare Conference, which ... New,York Palace Hotel in New York, NY. Mr. ...
... CHICAGO, Nov. 7 Easter Seals elected Missouri resident,Kent ... board,s,recent meeting., "Kent is a passionate advocate for ... from Easter Seals services and as a,volunteer leader," said ... Seals. "He is a dedicated board member, donor and,fund ...
Cached Medicine News:Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 2Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 3Health News:Allscripts Announces Notice of Offer to Purchase in Cash 3.50% Convertible Senior Debentures due 2024 4Health News:Sagent Pharmaceuticals Announces Presentations at Upcoming Lazard Capital Markets and Piper Jaffray Healthcare Conferences 2Health News:XanGo Introduces Glimpse(TM) Intuitive Skin Care 2Health News:XanGo Introduces Glimpse(TM) Intuitive Skin Care 3Health News:Acologix AC-200 Demonstrates Positive Effect on Bone in Preclinical Model of Chronic Kidney Disease 2Health News:Acologix AC-200 Demonstrates Positive Effect on Bone in Preclinical Model of Chronic Kidney Disease 3Health News:EntreMed to Present at the Rodman and Renshaw 10th Annual Healthcare Conference 2Health News:Easter Seals Elects Kent Schien, Chief Executive Officer of St. Louis-based Innoventor, to the Organization's International Board of Directors 2
... Featured Products are kept ... and are offered as ... regular or extra long ... with insulation, flush ports, ...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Operate with confidence. Autosuture is advancing the sate of both open and minimally invasive surgery by providing surgical tools that feel right, function right, and facilitate the right outcome eve...
Medicine Products: